Company Overview of H.D. Smith Wholesale Drug Co.

H. D. Smith announced the appointment of Tim Booth to executive vice president, Smith Medical Partners. Booth brings to Smith Medical Partners more than 20 years of experience in organizational business strategy, operations, sales and profitability management. In his new role, he will oversee Smith Medical Partners' operations, sales and company management and be responsible for achieving specific goals for the organization. Booth most recently served as corporate vice president of H. D. Smith's Home Healthcare operations. He joined H. D. Smith in 2012 as corporate vice president Home Healthcare where he established strategic methods for improving the company's home healthcare profit through vendor and customer relationships, sales leadership and distribution center coordination.

H.D. Smith Wholesale Drug Co. has announced the establishment of H. D. Smith Specialty Solutions, an organization structured to provide focus and alignment around specialty and traditional brand products, solutions and services. The company also announced the realignment of select executive leadership positions to best capitalize on the growing needs resulting from recent geographic and service expansions. These expansions include the acquisition of Valley Wholesale Drug in October 2012 and a planned majority ownership investment in Triplefin announced in January 2013. The structural change to the company is the formation of H. D. Smith Specialty Solutions, which will serve as the umbrella organization. H. D. Smith Specialty Solutions will be led by senior industry veteran Joseph Conda, who will serve as president. In addition to the creation of H. D. Smith Specialty Solutions, the company appointed the following senior executives to positions that best meet all customer needs, support growth and maximize H. D. Smith success: Tom Doyle promoted to serve as Executive Vice President Commercial Solutions: Doyle will lead the commercialization teams across Smith Medical Partners and Triplefin for the benefit of customers throughout the pharmaceutical supply chain, for both key products and services in key market segments. Karen Callaway promoted to serve as Executive Vice President Human Resources: Callaway will oversee the development and implementation of all human resources policies, programs and services. A member of the Executive Leadership Team, she will provide expertise on personnel issues that impact performance and business relationships. Bob Appleby promoted to serve as Senior Vice President Category Management: Appleby will lead all of the company's product category efforts. This includes branded and generic pharmaceuticals, home healthcare (HHC) products and the HHC sales organization as well as the health, beauty and wellness product category. Tom Twitty promoted to serve as Senior Vice President Supply Chain Management: Twitty will develop a company supply chain strategy that achieves company strategy and meets company performance objectives. His areas will include operations, purchasing, regulatory and compliance. Scott Wilson promoted to serve as Senior Vice President Drug Divisions: Wilson will lead the drug divisions, the sales organization and the Valley Wholesale Drug business, a wholly owned subsidiary. Mark Mehmet promoted to serve as Corporate Vice President Product Development and Architecture: Mehmet is responsible for product development to support business initiatives, leading production teams from initial inception to final product. In this role he will also identify and propose new information technologies and systems to improve business processes and decision making.

H.D. Smith Wholesale Drug Co. announced the appointment of Timothy Booth, MBA, to corporate vice president and head of its Home Healthcare Division. Mr. Booth will report to Christopher Smith, president and Chief Operating Officer, H. D. Smith. Most recently, he was an independent consultant providing guidance to companies in pharmaceutical industry strategy, operations, operating metrics, product pricing mechanisms, and technical and regulatory information.